Merge Healthcare has expanded options for shareholder value: RW Baird

With the resignation of Merge Healthcare (MRGE -0.4%) Chairman Michael Ferro, Jr, RW Baird sees avenues for increasing shareholder value expanding. One potential option is a take-private transaction.

Baird has an Overweight rating on the stock and a PT of $4.

Before Q2's abysmal report, Baird had a PT of $7 on Merge, freshly hiked from $5.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs